in

Bristol Myers Squibb and Century Therapeutics’ deal for $150M may enhance Seattle cell analysis

Bristol Myers Squibb and Century Therapeutics’ deal for $150M could boost Seattle cell research


Cell remedy firm Century Therapeutics will obtain a $100 million up entrance cost and $50 million in fairness funding from Bristol Myers Squibb in a deal introduced Monday. Underneath the settlement, Bristol Myers Squibb will develop and commercialize as much as 4 of Century’s applications for most cancers therapies constituted of induced pluripotent stem cells, which will be generated from grownup human tissue.

The settlement stands to bolster cell remedy analysis within the Seattle space. Bristol Myers Squibb’s cell remedy and immuno-oncology analysis hub is based mostly within the area, and Philadelphia-based Century has an “innovation hub” in Seattle.



What do you think?

Written by LessDaily.Com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0
Aviation startup ZeroAvia, backed by Amazon and Alaska Air, is building an R&D center near Seattle

Aviation startup ZeroAvia, backed by Amazon and Alaska Air, is constructing an R&D middle close to Seattle

NFL Week 18: Picks and preview

NFL Week 18: Picks and preview